HSV 1 LATENCY--IMMUNIZATION AND RECURRENT OCULAR DISEASE
HSV 1 LATENCY--IMMUNIZATION AND RECURRENT OCULAR DISEASE
批准号:
3260142
负责人:
Y JEROLD GORDON
金额:
$12.47万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-03-01 至 1988-02-29
中文摘要
拟议研究的长期目标是降低
复发性疱疹所致角膜盲的发生率
角膜炎。为实现这一长期目标而提出的第一个具体目标
目的包括评估活体减重的可行性
通过检验疱疹病毒疫苗的原始定植假说
携带HSV-1 TK毒株的三叉神经节将有效
用HSV-1 TK+野生型毒株防止二次定植。
具体地说,我们将确定是否可以占据一个以上的HSV-1毒株
潜伏期相同的神经节,如果HSV-1 TK强毒株
阻断野生型TK+菌株的定植和/或重新激活,如果
强毒型HSV-1毒株可与AFP互补或重组
无毒免疫病毒株产生潜伏的强毒株
能够产生复发性眼病的。隐匿性三叉神经
三叉神经与三叉神经共培养可检出疱疹病毒
神经节和离子导入引起的眼球流泪。已恢复
潜伏病毒将以Tk表型为特征,并通过
限制性内切酶分析。物种变异的作用来解释
目前文献中相互矛盾的结果将在老鼠身上进行评估。
还有兔子。实现以下长期目标的第二个具体目标
减少复发性疱疹病毒性角膜炎的失明包括阐明
潜伏期神经节细胞复活过程中的初始分子事件
疱疹。对早期基因转录的基本了解,包括
重新激活信号及其控制,对于实现第二个是必不可少的
长期目标。具体地说,我们将研究早期病毒RNA
原位杂交在神经节细胞中的转录。这些研究
将在兔身上使用6-羟基多巴胺加局部用药
肾上腺素离子导入诱发潜伏性神经节细胞再激活模型
疱疹病毒。这两个具体目标的结果将导致更好的
了解疱疹病毒潜伏期,并评估其潜伏期
活病毒疫苗的效力。
英文摘要
The long term ojbective of the proposed study is to reduce the high
incidence of corneal blindness resulting from recurrent herpetic
keratitis. The first proposed specific aim to meet this long term
objective includes evaluating the feasibility of a live, attenuated
herpesvirus vaccine by testing the hypothesis that primary colonization of
the trigeminal ganglia with an avirulent HSV-1 TK- strain will effectively
prevent secondary colonization with wild-type HSV-1 TK+ strains.
Specifically, we will determine if more than one HSV-1 strain can occupy
the same ganglion during latency, if an avirulent HSV-1 TK-strain will
block colonization and/or reactivation of wild-type TK+ strains, and if a
virulent challenge HSV-1 strain can complement or recombine with an
avirulent immunizing virus strain to produce a latent virulent strain
capable of producing recurrent ocular disease. Latent trigeminal
herpesvirus(es) will be detected by both co-cultivation of trigeminal
ganglia and iontophoresis-induced ocular shedding in tears. Recovered
latent viruses will be characterized by TK phenotype and identified by
restriction enzyme analysis. The role of species variations to explain
contradictory results in the current literature will be evaluated in mice
and rabbits. The second specific aim to achieve the long term objective of
reducing blindness from recurrent herpetic keratitis includes elucidating
the initial molecular events during reactivation of latent ganglionic
herpes. A basic understanding of early gene transcription, including the
reactivation signal and its control, is essential to achieve the second
long-term objective. Specifically, we will study early virus RNA
transcription in ganglionic neurons by in situ hybridization. The studies
will be carried out in rabbits using 6 hydroxydopamine plus topical
epinephrine iontophoresis model to induce reactivation of latent ganglionic
herpesvirus. The results of both specific aims will lead to a better
understanding of herpesvirus latency, and to an evaluation of the potential
efficacy of a live virus vaccine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EXPERIMENTAL PATHOGENESIS & THERAPY OF OCULAR ADENOVIRUS
-
批准号:6384613
-
项目类别:
-
资助金额:$31.47万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
EXPERIMENTAL PATHOGENESIS & THERAPY OF OCULAR ADENOVIRUS
-
批准号:3265441
-
项目类别:
-
资助金额:$21.08万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
Experimental Pathogenesis & Therapy of Ocular Adenovirus
-
批准号:6681766
-
项目类别:
-
资助金额:$42.83万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
EXPERIMENTAL PATHOGENESIS & THERAPY OF OCULAR ADENOVIRUS
-
批准号:2019730
-
项目类别:
-
资助金额:$30.18万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
EXPERIMENTAL PATHOGENESIS & THERAPY OF OCULAR ADENOVIRUS
-
批准号:2162111
-
项目类别:
-
资助金额:$27.39万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
Experimental Pathogenesis & Therapy of Ocular Adenovirus
-
批准号:7087716
-
项目类别:
-
资助金额:$43.35万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
EXPERIMENTAL PATHOGENESIS & THERAPY OF OCULAR ADENOVIRUS
-
批准号:2888343
-
项目类别:
-
资助金额:$30.15万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
EXPERIMENTAL PATHOGENESIS & THERAPY OF OCULAR ADENOVIRUS
-
批准号:3265440
-
项目类别:
-
资助金额:$25.09万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
EXPERIMENTAL PATHOGENESIS & THERAPY OF OCULAR ADENOVIRUS
-
批准号:3265439
-
项目类别:
-
资助金额:$23.4万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
Experimental Pathogenesis & Therapy of Ocular Adenovirus
-
批准号:6908885
-
项目类别:
-
资助金额:$43.81万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
Experimental Pathogenesis & Therapy of Ocular Adenovirus
-
批准号:6778175
-
项目类别:
-
资助金额:$43.24万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
EXPERIMENTAL PATHOGENESIS & THERAPY OF OCULAR ADENOVIRUS
-
批准号:2701375
-
项目类别:
-
资助金额:$29.51万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
EXPERIMENTAL PATHOGENESIS & THERAPY OF OCULAR ADENOVIRUS
-
批准号:6179895
-
项目类别:
-
资助金额:$30.8万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
EXPERIMENTAL PATHOGENESIS & THERAPY OF OCULAR ADENOVIRUS
-
批准号:2162110
-
项目类别:
-
资助金额:$26.53万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
EXPERIMENTAL PATHOGENESIS & THERAPY OF OCULAR ADENOVIRUS
-
批准号:2162112
-
项目类别:
-
资助金额:$28.23万
-
财政年份:1991
-
负责人:Y JEROLD GORDON
-
依托单位:
CELL BIOLOGY OF THE OCULAR SURFACE DISEASES
-
批准号:2159798
-
项目类别:
-
资助金额:$23.15万
-
财政年份:1985
-
负责人:Y JEROLD GORDON
-
依托单位:
HSV 1 LATENCY--IMMUNIZATION AND RECURRENT OCULAR DISEASE
-
批准号:3260144
-
项目类别:
-
资助金额:$19.62万
-
财政年份:1985
-
负责人:Y JEROLD GORDON
-
依托单位:
HSV 1 LATENCY--IMMUNIZATION AND RECURRENT OCULAR DISEASE
-
批准号:3260141
-
项目类别:
-
资助金额:$12.98万
-
财政年份:1985
-
负责人:Y JEROLD GORDON
-
依托单位:
HSV 1 LATENCY--IMMUNIZATION AND RECURRENT OCULAR DISEASE
-
批准号:3260138
-
项目类别:
-
资助金额:$19.14万
-
财政年份:1985
-
负责人:Y JEROLD GORDON
-
依托单位:
HSV 1 LATENCY--IMMUNIZATION AND RECURRENT OCULAR DISEASE
-
批准号:3260143
-
项目类别:
-
资助金额:$18.25万
-
财政年份:1985
-
负责人:Y JEROLD GORDON
-
依托单位:
海外基金